Showing results (291-300 of 468) with videos related to

Sort By:
Pageof 47
Nephrologie & Therapeutique|May 15, 2025
Intradialytic parenteral nutrition: theory and practical applicationCéline Pasian, Raymond Azar, Denis Fouque, et al.
Seminars in Dialysis|September 11, 2013
Do ketoanalogues still have a role in delaying dialysis initiation in CKD predialysis patients?Michel Aparicio, Vincenzo Bellizzi, Philippe Chauveau, et al.
Cancer Chemotherapy and Pharmacology|July 3, 2016
New insights into renal toxicity of the B-RAF inhibitor, vemurafenib, in patients with metastatic melanomaCécile Teuma, Marie Perier-Muzet, Solenne Pelletier, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 9, 2005
Dialyzer membrane permeability and survival in hemodialysis patientsPhilippe Chauveau, Hiep Nguyen, Christian Combe, et al.
Kidney International|October 24, 2018
Serum levels of the adipokine zinc-alpha2-glycoprotein (ZAG) predict mortality in hemodialysis patientsAnaïs Bouchara, Dan Yi, Myriam Pastural, et al.
European Cytokine Network|May 5, 2026
Propolis as a potential modulator of aryl hydrocarbon receptor signaling in inflammationNatália Alvarenga Borges, Larissa Manhães, Ludmilla Dias de Santana E Santana, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|January 8, 2021
To bee or not to bee? The bee extract propolis as a bioactive compound in the burden of lifestyle diseasesLivia Alvarenga, Ludmila F M F Cardozo, Natália A Borges, et al.
International Urology and Nephrology|June 20, 2018
The value of the Brazilian açai fruit as a therapeutic nutritional strategy for chronic kidney disease patientsIsabelle C V S Martins, Natália A Borges, Peter Stenvinkel, et al.
Journal of Nutrition and Metabolism|January 22, 2025
Effects of Tocotrienol on Cardiovascular Risk Markers in Patients With Chronic Kidney Disease: A Randomized Controlled TrialLiana Trugilho, Lívia Alvarenga, Ludmila Cardozo, et al.
The EPMA Journal|August 22, 2023
Royal jelly: a predictive, preventive and personalised strategy for novel treatment options in non-communicable diseasesBeatriz G Baptista, Ligia S Lima, Marcia Ribeiro, et al.
Pageof 47